1. National Cancer Institute Surveillance, Epidemiology, and End Results Program. Cancer Stat Fact Sheets. http://seer.cancer.gov/statfacts/html/urinb.html. Accessed on 8/1/2014.
2. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;von der Maase;J Clin Oncol,2005
3. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium;Sternberg;J Urol,1985
4. Combination chemotherapy (CISCA) for advanced urinary tract carcinoma. A preliminary report;Sternberg;JAMA,1977
5. Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer;Yagoda;Cancer Res,1977